FedCircuitBlog

This morning the Federal Circuit issued two nonprecedential opinions: one in a patent case appealed from a district court and the other in a veteran’s case appealed from the Court of Appeals for Veterans Claims. The court also issued two nonprecedential orders denying petitions for writs of mandamus: one regarding a stay of execution of a judgment in a patent case and the other regarding a motion to dismiss or transfer a patent case from the Western District of Texas to the Eastern District of Michigan. Here are the introductions to the opinions and orders.

This morning the Supreme Court issued its decision in Minerva Surgical, Inc. v. Hologic, Inc., a patent case reviewing the Federal Circuit’s approach to the doctrine of assignor estoppel. In a 5-4 split decision, the Court vacated and remanded the Federal Circuit’s judgment. In a majority opinion authored by Justice Kagan, the Supreme Court held that the Federal Circuit “was right to uphold” the doctrine but “failed to recognize the doctrine’s proper limits.” Here is a brief summary of the Court’s holding with quotations from Justice Kagan’s opinion as well as from dissenting opinions authored by Justices Alito and Barrett.

CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents – In an article on IPWatchDog, Logan Murr reports on the Federal Circuit’s denial of an en banc petition raising questions related to enablement filed by filed by Amgen Inc. in their case against Sanofi, Aventisub LLC. 

AWS Urges Supreme Court to Reject Oracle JEDI Review Petition – John Hewitt Jones writes for FedScoop.com about how “Amazon Web Services has filed a brief with the U.S. Supreme Court urging it to reject an earlier petition by Oracle to renew its challenge to the Pentagon’s $10 billion Joint Enterprise Defense Infrastructure (JEDI) contract.”

Federal Circuit Affirms Board Decision on Pandemic-Related Claim – On GovernmentContractsLegalForum.com, Steve McBrady, Charles Baek, Michelle Coleman, Rob Sneckenberg, John Nakoneczny, and Catherine Shames explain how the Federal Circuit “recently affirmed the Civilian Board of Contract Appeals’ (CBCA) decision denying a pandemic-related claim in Pernix Serka Joint Venture v. Secretary of State.”

Supreme Court Declines to Hear Cost Sharing Reduction Case – Susan Morse comments on HealthCareFinanceNews.com about how the Supreme Court will not hear a case decided by the Federal Circuit “regarding unpaid cost-sharing reduction payments to insurers.”

This morning, the Federal Circuit announced that the court has entered a new order concerning access to the National Courts Building complex in Washington, D.C., limiting access through August 31. Here is the text of today’s announcement.

This morning the Federal Circuit issued a nonprecedential opinion in a patent case affirming a decision of the United States District Court for the District of New Jersey related to the definiteness requirement. Here is the introduction to the opinion.

This week we are previewing two cases being argued next week at the Federal Circuit that attracted amicus briefs. Today we highlight a veterans case, Larson v. McDonough. In this case, Larson asks the Federal Circuit to overrule what he characterizes as the Veterans Court’s prohibition of reviewing Board of Veterans Appeals decisions regarding the Department of Veterans Affairs Schedule of Disabilities. This is our argument preview.

This morning the Federal Circuit issued a nonprecedential opinion in an inter partes review proceeding appealed from the Patent Trial and Appeal Board. The Federal Circuit affirmed the PTAB’s rejection of arguments certain claims were obvious in light of the prior art. Here is text from the opinion.

This past Monday, June 21, the Supreme Court decided United States v. Arthrex, Inc., Smith & Nephew, Inc. v. Arthrex, Inc., and Arthrex, Inc. v. Smith & Nephew, Inc. By a vote of five to four, the Court concluded that the statutory authority conferred upon the Patent Trial and Appeal Board to issue final decisions on behalf of the Executive Branch in inter partes review proceedings violates the Constitution’s Appointments Clause because the PTAB’s Administrative Patent Judges are not nominated by the President and confirmed by the Senate. Given this violation, the Court voted seven to two to sever the unconstitutional portion of the patent statute, giving the Director of the Patent and Trademark Office, who is nominated by the President and confirmed by the Senate, the power to review the PTAB’s decisions. Here is a summary of the Court’s opinions.

Justices Craft Their Own Remedy for Violation of Constitution’s Appointments Clause – George Quillin and Jeanne Gills post to SCOTUSblog about the Supreme Court’s decision this week in United States v. Arthrex.

Yu v. Apple Settles It: The CAFC is Suffering from a Prolonged Version of Alice in Wonderland Syndrome – Gene Quinn reports on IPWatchDog that “the Federal Circuit seems to be dealing with an exceptionally prolonged and worsening version of Alice in Wonderland syndrome.”

Amarin Rebuffed in High Court Bid to Revive Vascepa Patents – Susan Decker and Greg Stohr report for Bloomberg that the Supreme Court “declined to consider a bid by Amarin Corp. to revive six patents on the heart medicine Vascepa.”

Supreme Court Rebuffs Cost-Sharing Reduction Payment Appeal; $20 Million For State-Based Marketplaces – On HealthAffairs.org, Katie Keith notes “that two August decisions by a three-judge panel of the Court of Appeals for the Federal Circuit will stand.”

The Federal Circuit did not release any opinions or orders this morning on its website.